Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain

Journal of Neural Transmission

Volumn 103, Issue 8-9, 1996, Pages 1077-1081

  Mogi, M ^a   Harada, M ^a   Kondo, T ^b   Riederer, P ^c   Nagatsu, T ^d,e  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic fibroblast growth factor; Brain; Interleukin 2; Parkinson's disease

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 2; NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CORPUS STRIATUM; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0029802379     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01291792     Document Type: Article

References (24)

1. Bean AJ, Eide R, Cao YH, Oellig C, Tamminga C, Goldstein M, Pettersson RF. Hokfelt T (1991) Expression of acidic and basic fihroblast growth factors in the substantia nigra of rat, monkey, and human. Proc Natl Acad Sci USA 88: 10,237-10,241
2. Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proloferation and maturation by interleukin-2. Nature 321: 610-613
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4,546-1,550
5. Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ (1985) Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci 36: 213-228
6. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249-254
7. Ferrara N, Ousley F, Gospodarowicz D (1988) Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen. Brain Res 462: 223-232
8. Freed WJ, Morihisa JM, Spoor E, Hoffer BJ, Olson L, Seiger A, Wyatt RJ (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 292: 351-352
9. Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt T, Cox C, Waxman M, Gauger L (1989) Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320: 337-341
10. Greenfield SA (1992) Cell death in Parkinson's disease. In: Tipton KF (ed) Essays in biochemistry, vol 27. Portlend Press, London, pp 103-118
11. Grothe C, Unsicker K (1989) Immunocytochemical localization of basic fibroblast growth factor in bovine adrenal gland, ovary, and pituitary. J Histochem Cytochem 37: 1,877-1,883
12. Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224: 1,451-1,453
13. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
14. † -lesioned rat brain. Biochem Biophys Res Commun 165: 1,312-1,318
15. Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T (1987) Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content. Neurosci Lett 80: 213-218
16. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994a) Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208-210
17. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994b) Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth fator-α are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147-150
18. Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1995) Brain β2-microglobulin levels are elevated in the striatum in Parkison's disease. J Neural Transm [P-D Sect] 9: 87-92
19. Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1,007-1,008
20. Morrison RS, Kornblum HI, Leslie FM, Bradshaw RA (1987) Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science 238: 72-75
21. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912-1921
22. Sternberg EM (1989) Monokines, lymphokines and the brain. In: Cruse JM, Lewis Jr RE (eds) The year in immunology 1988: immunoregulatory cytokines and cell growth, vol 5, Karger, Basel, pp 205-217
23. Snyder SH (1991) Parkinson's disease, fresh factors to consider. Nature 350: 195
24. Yoshida K, Gage FH (1991) Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538: 118-126